US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

bioAffinity Technologies, Inc.

0.4966

-0.0184-3.57%

Volume:337.68K

Turnover:166.82K

Market Cap:8.89M

PE:-0.67

High:0.5480

Open:0.5050

Low:0.4610

Close:0.5150

Loading ...

Overview Company News Filings

BRIEF-Bioaffinity Technologies Increases Efficiency Of Cypath Lung Test

bioAffinity Technologies Increases Efficiency of Cypath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost

THOMSON REUTERS

BRIEF-Bioaffinity Technologies Files For Resale Of Up To 3.0 Million Shares Of Common Stock By Selling Stockholders - SEC Filing

bioAffinity Technologies Files for Resale of up to 3.0 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS

BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues

bioAffinity Technologies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

Nasdaq Surges 1%; US Construction Spending Rises In February

bioAffinity Technologies Cut to Hold From Buy by Maxim Group

US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert

BioAffinity Technologies Sees FY25 Revenue $6M-$8M.

BioAFfinity Technologies FY24 EPS (0.75) Up From ($0.91) YoY; Revenue $9.4 million Up From $2.5 Million YoY

Press Release: bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024

bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESS Newswire

Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer

BioAffinity accelerates CyPath Lung amid $4M in annual cost savings at PPLS

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive Cypath® Lung Sales Growth

THOMSON REUTERS

bioAffinity Technologies Inc - Announces 38% Workforce Reduction at Ppls

THOMSON REUTERS

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth

bioAffinity Technologies Raises $1.4 Million After Warrant Exercise

MT Newswires Live

WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BIAF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIAF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAF\",,,,,undefined,":{"symbol":"BIAF","market":"US","secType":"STK","nameCN":"bioAffinity Technologies, Inc.","latestPrice":0.4966,"timestamp":1745265600000,"preClose":0.515,"halted":0,"volume":337683,"delay":0,"floatShares":13118699,"shares":17906767,"eps":-0.745551,"marketStatus":"Post-Mkt","change":-0.0184,"latestTime":"04-21 18:18:58 EDT","open":0.505,"high":0.548,"low":0.461,"amount":166824.096682,"amplitude":0.168932,"askPrice":0.532,"askSize":100,"bidPrice":0.4482,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.745551,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"listingDate":1662004800000,"exchange":"NASDAQ","adjPreClose":0.515,"preHourTrading":{"tag":"盘前","latestPrice":0.5152,"preClose":0.5135,"latestTime":"09:15 EDT","volume":3687,"amount":1905.8099312999998,"timestamp":1745241328188},"volumeRatio":1.155484},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAF\",,,,,undefined,":{"symbol":"BIAF","floatShares":13118699,"roa":"-75.95%","roe":"-242.44%","lyrEps":-0.745551,"volumeRatio":1.155484,"shares":17906767,"dividePrice":0,"high":0.548,"amplitude":0.168932,"preClose":0.515,"low":0.461,"week52Low":0.2404,"pbRate":"3.42","psRate":"0.95","week52High":3.1626,"institutionHeld":0,"latestPrice":0.4966,"eps":-0.745551,"divideRate":0,"volume":337683,"delay":0,"ttmEps":-0.745551,"open":0.505,"prevYearClose":0.91,"prevWeekClose":0.515,"prevMonthClose":0.26,"prevQuarterClose":0.26,"fiveDayClose":0.5401,"twentyDayClose":0.2764,"sixtyDayClose":0.6303},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIAF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528104697","title":"BRIEF-Bioaffinity Technologies Increases Efficiency Of Cypath Lung Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2528104697","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528104697?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:21","pubTimestamp":1744896098,"startTime":"0","endTime":"0","summary":"BRIEF-Bioaffinity Technologies Increases Efficiency Of Cypath Lung Test April 17 (Reuters) - bioAffinity Technologies Inc BIAF.O:BIOAFFINITY TECHNOLOGIES INCREASES EFFICIENCY OF CYPATH LUNG TEST BY BO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA2PLPSY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0},{"id":"2528717095","title":"bioAffinity Technologies Increases Efficiency of Cypath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost","url":"https://stock-news.laohu8.com/highlight/detail?id=2528717095","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528717095?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:15","pubTimestamp":1744895700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA2PLPSY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0},{"id":"2526664759","title":"BRIEF-Bioaffinity Technologies Files For Resale  Of Up To 3.0 Million Shares Of Common Stock By Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2526664759","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526664759?lang=en_us&edition=fundamental","pubTime":"2025-04-12 05:53","pubTimestamp":1744408425,"startTime":"0","endTime":"0","summary":"BRIEF-Bioaffinity Technologies Files For Resale  Of Up To 3.0 Million Shares Of Common Stock By Selling Stockholders - SEC FilingApril 11  - bioAffinity Technologies Inc BIAF.O:BIOAFFINITY TECHNOLOGIES FILES FOR RESALE  OF UP TO 3.0 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILINGSource text: [ID:n0001641172-25-003892]Further company coverage: BIAF.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nFWN3QP1FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2526832647","title":"bioAffinity Technologies Files for Resale  of up to 3.0 Mln Shares of Common Stock by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2526832647","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526832647?lang=en_us&edition=fundamental","pubTime":"2025-04-12 05:46","pubTimestamp":1744407989,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nFWN3QP1FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2525020509","title":"BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2525020509","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525020509?lang=en_us&edition=fundamental","pubTime":"2025-04-08 00:16","pubTimestamp":1744042560,"startTime":"0","endTime":"0","summary":"Shares of bioAffinity Technologies, Inc. BIAF have surged 160.9% since the company reported its financial results for the year ended Dec. 31, 2024. In stark contrast, the S&P 500 Index declined 8.9% during the same period. Over the past month, BIAF stock notched an impressive gain of 89.3%, outperforming the S&P 500’s 9.7% slide.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.bioAffinity Technologies, Inc. Price, Consensus and EPS Surprise. bioAffinity Technologies, Inc. price-consensus-eps-surprise-chart | bioAffinity Technologies, Inc. Quote. President and CEO Maria Zannes emphasized that the record-breaking year validated the company’s growth strategy, especially through the integration of Precision Pathology and accelerated adoption of CyPath Lung. Zannes highlighted the test’s reimbursement by Medicare and private insurers, as well as its listing on the U.S. Federal Supply Schedule, enabling access to 1,380 government healthcare facilities. According to her,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biaf-stock-surges-post-improved-161600944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIAFW","BIAF","POST"],"gpt_icon":1},{"id":"2524084462","title":"bioAffinity Technologies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2524084462","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524084462?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:44","pubTimestamp":1743594266,"startTime":"0","endTime":"0","summary":"AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.NasdaqCM:BIAF Earnings and Revenue Growth April 2nd 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 2.2%. Earnings per share  exceeded analyst estimates by 8.5%.Looking ahead, revenue is expected to decline by 14% p.a. on average during the next 2 years, while revenues in the Biotechs industry in the US are expected to grow by 19%.The company's shares are up 278% from a week ago.Before we wrap up, we've discovered 6 warning signs for bioAffinity Technologies (5 are significant!","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioaffinity-technologies-full-2024-earnings-114426508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIAF","BIAFW"],"gpt_icon":0},{"id":"2524142954","title":"Nasdaq Surges 1%; US Construction Spending Rises In February","url":"https://stock-news.laohu8.com/highlight/detail?id=2524142954","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524142954?lang=en_us&edition=fundamental","pubTime":"2025-04-02 01:04","pubTimestamp":1743527080,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/04/44591098/nasdaq-surges-1-us-construction-spending-rises-in-february","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4588","LU2095319765.USD","BK4547","PSQ","QLD","IE00BGHQF748.EUR","NDAQ","TSYW.SI","LPRO","BK4112","USJW.SI","TQQQ","BK4202","IE00BKPKM429.USD","BK4149","BK4139","BK4585","PVH","USAW.SI","APTO","MVST","NQmain","NVIW.SI","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4020","MNQmain","CMBM","APTOF","QID","IE00B64PRP62.GBP","LU2210150020.SGD",".IXIC","SQQQ"],"gpt_icon":1},{"id":"2524119651","title":"bioAffinity Technologies Cut to Hold From Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2524119651","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524119651?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:01","pubTimestamp":1743512460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIAF/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 09:01 ET (13:01 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2524166867","title":"US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert","url":"https://stock-news.laohu8.com/highlight/detail?id=2524166867","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524166867?lang=en_us&edition=fundamental","pubTime":"2025-04-01 16:59","pubTimestamp":1743497951,"startTime":"0","endTime":"0","summary":"U.S. stock futures were swinging between gains and losses on Tuesday after a mixed session on Monday. Futures of major benchmark indices were mixed in premarket trading.\n\n\n\nPresident Donald Trump‘s “Liberation Day”, the term he’s used for April 2nd, the day of incoming reciprocal tariffs, preceded a drop in stock prices.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44579542/us-stock-likely-to-open-mixed-after-a-disappointing-q1-performance-april-does-better-after-a-weak-q1-says-expert","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","2NVD.UK","NQmain",".SPX","ESmain","NVD3.UK","USAW.SI","NVD2.UK","SQQQ","MVST","NVDX","QID","TSYW.SI","ULBI","QLD","NCNO","USJW.SI","3NVD.UK","CSAI","EVS.SI","SPY","NEE","SONM","OEF","PSQ","NVDU","NVDS.UK","SPWH","VOO","PVH","QQQ","TGT","SNVD.UK","IVV","ALLR",".IXIC","BIAF","OEX","NVDY","UPRO","GHI","SDS","TQQQ","MNQmain"],"gpt_icon":1},{"id":"2523394201","title":"BioAffinity Technologies Sees FY25 Revenue $6M-$8M.","url":"https://stock-news.laohu8.com/highlight/detail?id=2523394201","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523394201?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:37","pubTimestamp":1743428269,"startTime":"0","endTime":"0","summary":"BioAffinity Technologies Sees FY25 Revenue $6M-$8M.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44562130/bioaffinity-technologies-sees-fy25-revenue-6m-8m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BIAFW"],"gpt_icon":0},{"id":"2523942016","title":"BioAFfinity Technologies FY24 EPS (0.75) Up From ($0.91) YoY; Revenue $9.4 million Up From $2.5 Million YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2523942016","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523942016?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:36","pubTimestamp":1743428204,"startTime":"0","endTime":"0","summary":"BioAFfinity Technologies FY24 EPS (0.75) Up From ($0.91) YoY; Revenue $9.4 million Up From $2.5 Million YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44562026/bioaffinity-technologies-fy24-eps-0-75-up-from-0-91-yoy-revenue-9-4-million-up-from-2-5-million-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BIAFW"],"gpt_icon":0},{"id":"2523426729","title":"Press Release: bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2523426729","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523426729?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:28","pubTimestamp":1743427680,"startTime":"0","endTime":"0","summary":"Increased Demand, Expanded Insurance Coverage Drive Record Growth. bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today reported financial results for the year ended December 31, 2024.-- Record Revenue: Revenue grew approximately 270% to $9.4 million in 2024,a significant increase from $2.5 million in 2023.-- Increased Demand: CyPath Lung orders grew by approximately 1,400% over. -- CyPath Lung Reimbursed by Medicare and Private Insurance: The unique. CPT code for CyPath Lung was added to the Centers for Medicare and. January 1, leading to reimbursement of the test by both Medicare and. by over 300% in 2024, positioning the Company for continued growth in. -- Federal Supply Schedule  Listing: In October 2024, CyPath Lung. to the test. Through 1,380 government healthcare facilities, Veterans at. and Outcomes Research concluded that adding CyPath Lung to the","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF"],"gpt_icon":0},{"id":"2522057297","title":"bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV","url":"https://stock-news.laohu8.com/highlight/detail?id=2522057297","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522057297?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:00","pubTimestamp":1743166800,"startTime":"0","endTime":"0","summary":"ORLANDO, FLORIDA / ACCESS Newswire / March 28, 2025 / RedChip Companies will air interviews with bioAffinity Technologies, Inc.  and Can-Fite BioPharma Ltd.  on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV this Saturday, March 29, at 7 p.m. Eastern Time . Bloomberg TV is available in an estimated 73 million homes across the U.S.Motti Farbstein, Chief Executive Officer of Can-Fite, appears on the RedChip Small Stocks Big Money show on Bloomberg TV to discuss the company's current development pipeline and upcoming milestones. Strategically positioned with multiple out-licensing deals and potential regulatory and sales milestone payments totaling over $130 million, Can-Fite has already received $20 million in upfront and milestone payments, underscoring the potential of its therapies. With advanced-stage assets targeting unmet medical needs in markets with a combined value in excess of $70 billion, Can-Fite believes that it is well positioned for the poten","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioaffinity-technologies-fite-biopharma-interviews-130000535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TV","TM","BK4590","BK4581","BK4585","BK4588","BK4100","BK4187","BK4006","BK4099","03160","AIRI","BIAFW","BK4561","BK4144","CANF","BK4555","HCC","BIAF","ET","BK4604"],"gpt_icon":0},{"id":"2519983452","title":"Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2519983452","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519983452?lang=en_us&edition=fundamental","pubTime":"2025-03-13 21:00","pubTimestamp":1741870800,"startTime":"0","endTime":"0","summary":"SAN ANTONIO, March 13, 2025----bioAffinity Technologies, Inc.  announced the release of physicians’ case studies showing the benefit to patients and their doctors of using CyPath Lung, the Company’s noninvasive test for early detection of lung cancer.The study, authored by pulmonologists Michael Morris, MD, and Sheila Habib, MD, found that an average cost savings of $2,773 per patient would have been achieved in 2022 if CyPath Lung had been part of the standard of care for Medicare patients with a positive lung cancer screening, for a total of $379 million. The study, \"Economic Evaluation of a Novel Lung Cancer Diagnostic in a Population of Patients with a Positive Low-Dose Computed Tomography Result,\" attributes the savings to a reduction in follow-up diagnostic assessments, expensive follow-up procedures and procedure-related complications. The study also found that adding CyPath Lung to the standard of care for private-payer patients with a positive lung cancer screening result coul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/physicians-case-studies-offer-insight-130000674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INAQU","BIAFW","BIAF"],"gpt_icon":0},{"id":"2517315775","title":"BioAffinity accelerates CyPath Lung amid $4M in annual cost savings at PPLS","url":"https://stock-news.laohu8.com/highlight/detail?id=2517315775","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517315775?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:31","pubTimestamp":1741267863,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies (BIAF), announced targeted strategic actions to improve financial performance and accelerate the commercial growth of CyPa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioaffinity-accelerates-cypath-lung-amid-4m-in-annual-cost-savings-at-ppls?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioaffinity-accelerates-cypath-lung-amid-4m-in-annual-cost-savings-at-ppls?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2517947154","title":"bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive Cypath® Lung Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2517947154","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517947154?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA3PXM0V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIAFW","BIAF"],"gpt_icon":0},{"id":"2517615411","title":"bioAffinity Technologies Inc - Announces 38% Workforce Reduction at Ppls","url":"https://stock-news.laohu8.com/highlight/detail?id=2517615411","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517615411?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA3PXM0V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIAFW","BIAF"],"gpt_icon":0},{"id":"2517527691","title":"bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2517527691","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517527691?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266000,"startTime":"0","endTime":"0","summary":"Proactive steps reinforce bioAffinity Technologies’ laser focus on accelerating CyPath Lung sales growth in strategic national markets. Decreases labor and overhead costs, including 38% workforce reduction in non-CyPath Lung personnel at Company’s subsidiary laboratory. \"Our strategic adjustments today enhance our readiness to serve the market for noninvasive lung cancer detection in both civilian and military healthcare systems, and we continue to see increasing sales as more and more physicians incorporate CyPath Lung into their protocol for patients at high risk for lung cancer,\" Maria Zannes, President and Chief Executive Officer, said. \"With CyPath Lung now available for purchase through","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioaffinity-technologies-announces-targeted-actions-130000588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIAFW","BIAF"],"gpt_icon":0},{"id":"2514654068","title":"bioAffinity Technologies Raises $1.4 Million After Warrant Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2514654068","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514654068?lang=en_us&edition=fundamental","pubTime":"2025-02-27 01:58","pubTimestamp":1740592706,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies  said Wednesday it raised $1.4 million after four investors agreed to exchange their warrants for shares in the company.The warrants were exercised for 2,438,473 shares at $0.58 each.In exchange, the company said it issued new warrants to buy up to 2,926,166 shares at $0.85 per share, subject to stockholder approval.Shares of bioAffinity Technologies were down over 9% in recent trading.Price: 0.61, Change: -0.06, Percent Change: -9.30","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2514486336","title":"WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514486336","media":"PR Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514486336?lang=en_us&edition=fundamental","pubTime":"2025-02-27 01:10","pubTimestamp":1740589800,"startTime":"0","endTime":"0","summary":"JERSEY CITY, N.J., Feb. 26, 2025 /PRNewswire/ --WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that – bioAffinity Technologies, Inc.  announced today it has closed its previously announced warrant exercise agreements with four existing accredited investors to exercise certain outstanding warrants to purchase an aggregate of 2,438,473 of the Company's shares of common stock . In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of approximately $1.4 million, the exercising holders will receive in a private placement new unregistered warrants  to purchase up to an aggregate of 2,926,166 shares of common stock  with an exercise price of $0.85 per share. The New Warrants are initially exercisable on the date that stockholder approval of the exercise of the New Warrants is obtained and will expire five years from the date of such approval. In connection with the exercise of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/wallachbeth-capital-announces-closing-bioaffinity-171000778.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wallachbeth-capital-announces-closing-bioaffinity-171000778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BIAFW","BIAF"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIAF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"BIAF","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2024-05-15","symbol":"BIAF","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2024-04-01","symbol":"BIAF","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711944000000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2023-11-14","symbol":"BIAF","fiscalQuarterEnding":"2023/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2022-06-24","symbol":"BIAF","defaultRemindTime":1656077400000,"type":"split","dateTimestamp":1656043200000,"forFactor":1000000,"toFactor":142857,"ratio":7.000007000007}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIAF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIAF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1743566400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIAF\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIAF","date":"2025-04-17","current":-0.930218,"percent":0.96129,"low":-7.049629,"twenty":-2.686893,"median":-1.950745,"eighty":-1.346778,"high":-0.479749,"avg":-2.064973,"sd":0.821042,"marketCap":8409017},"quantilePoints":[{"date":"2022-06-24","current":-2.566585,"twenty":-2.566585,"median":-2.566585,"eighty":-2.566585,"marketCap":18177210},{"date":"2022-06-27","current":-2.566585,"twenty":-2.566585,"median":-2.566585,"eighty":-2.566585,"marketCap":18177210},{"date":"2022-08-11","current":-2.358916,"twenty":-2.566585,"median":-2.358916,"eighty":-2.358916,"marketCap":16706445},{"date":"2022-09-02","current":-5.987938,"twenty":-4.619397,"median":-2.46275,"eighty":-2.358916,"marketCap":51799882},{"date":"2022-09-09","current":-4.059907,"twenty":-4.863395,"median":-3.313246,"eighty":-2.358916,"marketCap":35121054},{"date":"2022-09-16","current":-3.652217,"twenty":-4.741088,"median":-3.89853,"eighty":-2.40045,"marketCap":31594254},{"date":"2022-09-23","current":-1.792135,"twenty":-4.487981,"median":-3.376177,"eighty":-2.358916,"marketCap":15503227},{"date":"2022-09-30","current":-2.471617,"twenty":-4.114265,"median":-2.819851,"eighty":-2.358916,"marketCap":21381227},{"date":"2022-10-07","current":-2.505591,"twenty":-4.053112,"median":-2.557322,"eighty":-2.358916,"marketCap":21675127},{"date":"2022-10-14","current":-2.225304,"twenty":-4.000452,"median":-2.497097,"eighty":-2.347154,"marketCap":19250452},{"date":"2022-10-21","current":-2.216811,"twenty":-3.849267,"median":-2.475863,"eighty":-2.347154,"marketCap":19176977},{"date":"2022-10-28","current":-2.378188,"twenty":-3.625038,"median":-2.463123,"eighty":-2.315336,"marketCap":20573002},{"date":"2022-11-04","current":-2.233798,"twenty":-3.460264,"median":-2.45463,"eighty":-2.315336,"marketCap":19323927},{"date":"2022-11-11","current":-2.403668,"twenty":-3.212252,"median":-2.420656,"eighty":-2.252484,"marketCap":20793427},{"date":"2022-11-18","current":-1.777191,"twenty":-3.05767,"median":-2.378188,"eighty":-2.225304,"marketCap":21426560},{"date":"2022-11-25","current":-1.80496,"twenty":-2.819851,"median":-2.378188,"eighty":-2.131876,"marketCap":21761350},{"date":"2022-12-02","current":-2.040993,"twenty":-2.666968,"median":-2.361201,"eighty":-1.922976,"marketCap":24607065},{"date":"2022-12-09","current":-1.402315,"twenty":-2.566585,"median":-2.358916,"eighty":-1.874381,"marketCap":16906895},{"date":"2022-12-16","current":-1.367604,"twenty":-2.566585,"median":-2.344214,"eighty":-1.832728,"marketCap":16488407},{"date":"2022-12-23","current":-1.284298,"twenty":-2.548059,"median":-2.305993,"eighty":-1.80496,"marketCap":15484037},{"date":"2022-12-30","current":-1.110745,"twenty":-2.514085,"median":-2.255032,"eighty":-1.798929,"marketCap":13391600},{"date":"2023-01-06","current":-1.110745,"twenty":-2.500495,"median":-2.242292,"eighty":-1.623075,"marketCap":13391600},{"date":"2023-01-13","current":-1.152467,"twenty":-2.486905,"median":-2.225304,"eighty":-1.388472,"marketCap":13894621},{"date":"2023-01-20","current":-1.055207,"twenty":-2.476713,"median":-2.174343,"eighty":-1.310679,"marketCap":12722020},{"date":"2023-01-27","current":-1.994133,"twenty":-2.468219,"median":-2.120828,"eighty":-1.310679,"marketCap":24042106},{"date":"2023-02-03","current":-1.652232,"twenty":-2.463123,"median":-2.040993,"eighty":-1.338447,"marketCap":19920005},{"date":"2023-02-10","current":-1.423211,"twenty":-2.459726,"median":-1.972439,"eighty":-1.375935,"marketCap":17158824},{"date":"2023-02-17","current":-1.430084,"twenty":-2.45463,"median":-1.922976,"eighty":-1.388459,"marketCap":17241685},{"date":"2023-02-24","current":-1.249588,"twenty":-2.45463,"median":-1.909092,"eighty":-1.350943,"marketCap":15065550},{"date":"2023-03-03","current":-1.214877,"twenty":-2.449534,"median":-1.839671,"eighty":-1.294017,"marketCap":14647062},{"date":"2023-03-10","current":-1.062149,"twenty":-2.42745,"median":-1.832728,"eighty":-1.249588,"marketCap":12805717},{"date":"2023-03-17","current":-1.166282,"twenty":-2.417258,"median":-1.815373,"eighty":-1.209323,"marketCap":14061180},{"date":"2023-03-24","current":-1.270414,"twenty":-2.398572,"median":-1.80496,"eighty":-1.202381,"marketCap":15316642},{"date":"2023-03-31","current":-1.312067,"twenty":-2.378188,"median":-1.80496,"eighty":-1.207935,"marketCap":15818827},{"date":"2023-04-06","current":-1.847601,"twenty":-2.378188,"median":-1.802794,"eighty":-1.200992,"marketCap":15065550},{"date":"2023-04-14","current":-1.652577,"twenty":-2.378188,"median":-1.800628,"eighty":-1.207935,"marketCap":13475297},{"date":"2023-04-21","current":-1.888933,"twenty":-2.378188,"median":-1.802794,"eighty":-1.207935,"marketCap":15402574},{"date":"2023-04-28","current":-2.034236,"twenty":-2.369694,"median":-1.80496,"eighty":-1.214877,"marketCap":16587387},{"date":"2023-05-05","current":-2.060629,"twenty":-2.361201,"median":-1.805752,"eighty":-1.214877,"marketCap":16802598},{"date":"2023-05-12","current":-1.945568,"twenty":-2.358916,"median":-1.818844,"eighty":-1.221819,"marketCap":15864382},{"date":"2023-05-18","current":-1.86888,"twenty":-2.358916,"median":-1.832728,"eighty":-1.232926,"marketCap":15352628},{"date":"2023-05-26","current":-1.991074,"twenty":-2.358916,"median":-1.839671,"eighty":-1.244034,"marketCap":16356443},{"date":"2023-06-01","current":-1.897743,"twenty":-2.358916,"median":-1.843636,"eighty":-1.249588,"marketCap":15589735},{"date":"2023-06-09","current":-2.001445,"twenty":-2.355976,"median":-1.86888,"eighty":-1.249588,"marketCap":16441633},{"date":"2023-06-16","current":-1.856262,"twenty":-2.342515,"median":-1.871631,"eighty":-1.249588,"marketCap":15248975},{"date":"2023-06-23","current":-1.794041,"twenty":-2.33572,"median":-1.857029,"eighty":-1.249588,"marketCap":14737837},{"date":"2023-06-30","current":-1.845892,"twenty":-2.315336,"median":-1.851932,"eighty":-1.249588,"marketCap":15163786},{"date":"2023-07-07","current":-1.928853,"twenty":-2.305144,"median":-1.856262,"eighty":-1.253753,"marketCap":15845304},{"date":"2023-07-14","current":-1.825151,"twenty":-2.276266,"median":-1.847601,"eighty":-1.26486,"marketCap":14993406},{"date":"2023-07-21","current":-1.866632,"twenty":-2.254183,"median":-1.846747,"eighty":-1.270414,"marketCap":15334165},{"date":"2023-07-28","current":-1.877002,"twenty":-2.250785,"median":-1.845892,"eighty":-1.273191,"marketCap":15419355},{"date":"2023-08-04","current":-1.835522,"twenty":-2.247388,"median":-1.846747,"eighty":-1.285686,"marketCap":15078596},{"date":"2023-08-11","current":-1.887373,"twenty":-2.232099,"median":-1.845892,"eighty":-1.294017,"marketCap":15504545},{"date":"2023-08-18","current":-1.62887,"twenty":-2.225304,"median":-1.842782,"eighty":-1.306513,"marketCap":16072062},{"date":"2023-08-24","current":-1.607329,"twenty":-2.225304,"median":-1.839463,"eighty":-1.312067,"marketCap":15859525},{"date":"2023-09-01","current":-1.53986,"twenty":-2.21851,"median":-1.835522,"eighty":-1.312067,"marketCap":15193808},{"date":"2023-09-08","current":-1.530959,"twenty":-2.199824,"median":-1.835522,"eighty":-1.314844,"marketCap":15105982},{"date":"2023-09-14","current":-1.44195,"twenty":-2.182837,"median":-1.832728,"eighty":-1.317621,"marketCap":14227727},{"date":"2023-09-22","current":-0.943498,"twenty":-2.157356,"median":-1.828939,"eighty":-1.314844,"marketCap":9309500},{"date":"2023-09-29","current":-1.032507,"twenty":-2.13103,"median":-1.825151,"eighty":-1.294017,"marketCap":10187755},{"date":"2023-10-06","current":-1.201625,"twenty":-2.129337,"median":-1.825151,"eighty":-1.278744,"marketCap":11856439},{"date":"2023-10-13","current":-1.183912,"twenty":-2.127644,"median":-1.825151,"eighty":-1.266525,"marketCap":11681667},{"date":"2023-10-20","current":-1.201625,"twenty":-2.127644,"median":-1.818844,"eighty":-1.249588,"marketCap":11856439},{"date":"2023-10-27","current":-1.326238,"twenty":-2.127644,"median":-1.816544,"eighty":-1.252365,"marketCap":13085996},{"date":"2023-11-03","current":-1.148219,"twenty":-2.126306,"median":-1.810749,"eighty":-1.249588,"marketCap":11329486},{"date":"2023-11-10","current":-1.317337,"twenty":-2.123935,"median":-1.80496,"eighty":-1.242173,"marketCap":12998171},{"date":"2023-11-17","current":-1.735051,"twenty":-2.120976,"median":-1.80496,"eighty":-1.249588,"marketCap":12559043},{"date":"2023-11-24","current":-1.837849,"twenty":-2.117339,"median":-1.80496,"eighty":-1.249588,"marketCap":13303140},{"date":"2023-12-01","current":-2.179164,"twenty":-2.117339,"median":-1.806544,"eighty":-1.249588,"marketCap":15773723},{"date":"2023-12-08","current":-1.995379,"twenty":-2.117339,"median":-1.813341,"eighty":-1.249588,"marketCap":14443409},{"date":"2023-12-15","current":-1.890359,"twenty":-2.11519,"median":-1.816544,"eighty":-1.250976,"marketCap":13683229},{"date":"2023-12-22","current":-1.916614,"twenty":-2.106539,"median":-1.824721,"eighty":-1.256675,"marketCap":13873274},{"date":"2023-12-29","current":-2.192291,"twenty":-2.117284,"median":-1.825151,"eighty":-1.257111,"marketCap":15868745},{"date":"2024-01-05","current":-1.916614,"twenty":-2.117321,"median":-1.825151,"eighty":-1.259926,"marketCap":13873274},{"date":"2024-01-12","current":-2.094491,"twenty":-2.113114,"median":-1.825151,"eighty":-1.266525,"marketCap":15160828},{"date":"2024-01-19","current":-2.01507,"twenty":-2.106539,"median":-1.832728,"eighty":-1.270414,"marketCap":14585943},{"date":"2024-01-26","current":-2.080707,"twenty":-2.104197,"median":-1.835522,"eighty":-1.271503,"marketCap":15061055},{"date":"2024-02-02","current":-2.021634,"twenty":-2.104197,"median":-1.837849,"eighty":-1.277052,"marketCap":14633454},{"date":"2024-02-09","current":-2.061016,"twenty":-2.100399,"median":-1.837849,"eighty":-1.281982,"marketCap":14918521},{"date":"2024-02-16","current":-1.982251,"twenty":-2.100399,"median":-1.839671,"eighty":-1.282958,"marketCap":14348386},{"date":"2024-02-23","current":-1.864104,"twenty":-2.100399,"median":-1.844413,"eighty":-1.284298,"marketCap":13493185},{"date":"2024-03-01","current":-3.045578,"twenty":-2.106887,"median":-1.846747,"eighty":-1.29124,"marketCap":22045203},{"date":"2024-03-08","current":-2.034761,"twenty":-2.117357,"median":-1.850976,"eighty":-1.299535,"marketCap":14728476},{"date":"2024-03-15","current":-2.799727,"twenty":-2.127644,"median":-1.85621,"eighty":-1.299535,"marketCap":20265625},{"date":"2024-03-22","current":-3.226804,"twenty":-2.174343,"median":-1.857797,"eighty":-1.305125,"marketCap":23356992},{"date":"2024-03-28","current":-3.290074,"twenty":-2.197195,"median":-1.866632,"eighty":-1.310679,"marketCap":23814972},{"date":"2024-04-05","current":-3.721769,"twenty":-2.225304,"median":-1.875692,"eighty":-1.312067,"marketCap":29539725},{"date":"2024-04-12","current":-3.409184,"twenty":-2.252484,"median":-1.878554,"eighty":-1.316283,"marketCap":27058731},{"date":"2024-04-19","current":-4.047499,"twenty":-2.337419,"median":-1.887373,"eighty":-1.317337,"marketCap":32125047},{"date":"2024-04-26","current":-3.496227,"twenty":-2.358916,"median":-1.888933,"eighty":-1.318675,"marketCap":27749593},{"date":"2024-05-03","current":-3.322141,"twenty":-2.371393,"median":-1.894051,"eighty":-1.319009,"marketCap":26367870},{"date":"2024-05-10","current":-2.930448,"twenty":-2.380496,"median":-1.903486,"eighty":-1.324792,"marketCap":23258995},{"date":"2024-05-17","current":-3.371987,"twenty":-2.422355,"median":-1.908084,"eighty":-1.34267,"marketCap":28210167},{"date":"2024-05-24","current":-3.38575,"twenty":-2.456329,"median":-1.916614,"eighty":-1.363439,"marketCap":28325310},{"date":"2024-05-31","current":-3.330698,"twenty":-2.475014,"median":-1.920868,"eighty":-1.369487,"marketCap":27864736},{"date":"2024-06-07","current":-3.126113,"twenty":-2.555469,"median":-1.925914,"eighty":-1.381356,"marketCap":26462608},{"date":"2024-06-14","current":-2.936249,"twenty":-2.635174,"median":-1.928853,"eighty":-1.388459,"marketCap":24564761},{"date":"2024-06-21","current":-2.591791,"twenty":-2.696804,"median":-1.932424,"eighty":-1.389875,"marketCap":21683018},{"date":"2024-06-28","current":-2.968019,"twenty":-2.720158,"median":-1.935984,"eighty":-1.392624,"marketCap":24830553},{"date":"2024-07-05","current":-3.023756,"twenty":-2.794585,"median":-1.942395,"eighty":-1.395373,"marketCap":25296855},{"date":"2024-07-12","current":-3.399984,"twenty":-2.87532,"median":-1.950745,"eighty":-1.39815,"marketCap":28444390},{"date":"2024-07-15","current":-3.567196,"twenty":-2.892729,"median":-1.953371,"eighty":-1.399538,"marketCap":29843294},{"date":"2024-08-02","current":-3.316378,"twenty":-2.907236,"median":-1.955996,"eighty":-1.400927,"marketCap":27744938},{"date":"2024-08-09","current":-2.533442,"twenty":-2.889827,"median":-1.959964,"eighty":-1.402315,"marketCap":21194865},{"date":"2024-08-16","current":-2.384759,"twenty":-2.863715,"median":-1.969124,"eighty":-1.407869,"marketCap":20833589},{"date":"2024-08-23","current":-2.678705,"twenty":-2.829511,"median":-1.969729,"eighty":-1.414811,"marketCap":23401547},{"date":"2024-08-30","current":-2.393496,"twenty":-2.820363,"median":-1.976948,"eighty":-1.421809,"marketCap":20909923},{"date":"2024-09-06","current":-2.138705,"twenty":-2.807777,"median":-1.982251,"eighty":-1.427335,"marketCap":18684028},{"date":"2024-09-13","current":-2.547915,"twenty":-2.792014,"median":-1.989241,"eighty":-1.434249,"marketCap":22258950},{"date":"2024-09-20","current":-3.103824,"twenty":-2.814197,"median":-1.994133,"eighty":-1.43998,"marketCap":27115448},{"date":"2024-09-27","current":-3.042056,"twenty":-2.869518,"median":-1.995379,"eighty":-1.455656,"marketCap":26575837},{"date":"2024-10-04","current":-2.887637,"twenty":-2.923292,"median":-1.995379,"eighty":-1.483558,"marketCap":25226810},{"date":"2024-10-11","current":-2.980289,"twenty":-2.932768,"median":-2.002272,"eighty":-1.506321,"marketCap":26036226},{"date":"2024-10-18","current":-3.289127,"twenty":-2.972927,"median":-2.01507,"eighty":-1.523838,"marketCap":28734281},{"date":"2024-10-25","current":-1.992007,"twenty":-2.956851,"median":-2.021634,"eighty":-1.532989,"marketCap":17402452},{"date":"2024-10-31","current":-2.115542,"twenty":-2.944143,"median":-2.021634,"eighty":-1.536549,"marketCap":18481674},{"date":"2024-11-08","current":-2.038332,"twenty":-2.933929,"median":-2.021634,"eighty":-1.53986,"marketCap":17807160},{"date":"2024-11-15","current":-2.053774,"twenty":-2.925677,"median":-2.02191,"eighty":-1.53986,"marketCap":17942063},{"date":"2024-11-22","current":-2.278807,"twenty":-2.911686,"median":-2.025706,"eighty":-1.540379,"marketCap":19247024},{"date":"2024-11-29","current":-2.241903,"twenty":-2.898674,"median":-2.034761,"eighty":-1.544459,"marketCap":18935331},{"date":"2024-12-06","current":-1.946673,"twenty":-2.887637,"median":-2.034498,"eighty":-1.559915,"marketCap":16441789},{"date":"2024-12-13","current":-1.796844,"twenty":-2.887495,"median":-2.025706,"eighty":-1.574592,"marketCap":15176317},{"date":"2024-12-20","current":-2.177321,"twenty":-2.881123,"median":-2.023021,"eighty":-1.597881,"marketCap":18389869},{"date":"2024-12-27","current":-1.752928,"twenty":-2.857912,"median":-2.021634,"eighty":-1.600387,"marketCap":14805403},{"date":"2025-01-03","current":-1.734661,"twenty":-2.856986,"median":-2.021634,"eighty":-1.60117,"marketCap":14651115},{"date":"2025-01-10","current":-1.699602,"twenty":-2.836148,"median":-2.018352,"eighty":-1.601847,"marketCap":14355007},{"date":"2025-01-17","current":-1.335731,"twenty":-2.820875,"median":-2.007448,"eighty":-1.564421,"marketCap":11281717},{"date":"2025-01-24","current":-1.163022,"twenty":-2.816082,"median":-2.001445,"eighty":-1.53986,"marketCap":9822995},{"date":"2025-01-31","current":-1.429282,"twenty":-2.810428,"median":-1.995379,"eighty":-1.520278,"marketCap":12071858},{"date":"2025-02-07","current":-1.549958,"twenty":-2.806148,"median":-1.995379,"eighty":-1.476717,"marketCap":13091093},{"date":"2025-02-14","current":-1.47615,"twenty":-2.794585,"median":-1.993467,"eighty":-1.461865,"marketCap":12467708},{"date":"2025-02-21","current":-1.494602,"twenty":-2.780852,"median":-1.992007,"eighty":-1.460888,"marketCap":12623554},{"date":"2025-02-28","current":-0.963926,"twenty":-2.75515,"median":-1.991074,"eighty":-1.443623,"marketCap":8141413},{"date":"2025-03-07","current":-0.701171,"twenty":-2.745155,"median":-1.982251,"eighty":-1.43747,"marketCap":5922161},{"date":"2025-03-14","current":-0.653934,"twenty":-2.729886,"median":-1.976948,"eighty":-1.424425,"marketCap":5523194},{"date":"2025-03-21","current":-0.517575,"twenty":-2.72248,"median":-1.97152,"eighty":-1.402315,"marketCap":4371490},{"date":"2025-03-28","current":-0.499123,"twenty":-2.711125,"median":-1.969124,"eighty":-1.395373,"marketCap":4215643},{"date":"2025-04-04","current":-1.208694,"twenty":-2.703877,"median":-1.960774,"eighty":-1.389313,"marketCap":10926387},{"date":"2025-04-11","current":-1.109488,"twenty":-2.699246,"median":-1.959964,"eighty":-1.373373,"marketCap":10029580},{"date":"2025-04-17","current":-0.930218,"twenty":-2.686893,"median":-1.950745,"eighty":-1.346778,"marketCap":8409017}],"updateTime":1745262094500}}}